BioXcel Therapeutics Raises $8M via Direct Offering Amid Market Challenges
BioXcel Therapeutics raises $8M via direct offering of 4.5M shares at $1.739/share, with warrant modifications agreed, closing expected March 2026.
BTAIartificial intelligencewarrants